Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Mar-23 10:00 PM View:  | Allogene Therapeutics, Inc. (ALLO) | 14-Mar-23 | Payment of Exercise | 23,628 | $5.67 | $133,971.00 | (4%) 579.68K to 556.05K | |
| 14-Feb-23 5:10 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-Feb-23 | Sale | 3,000 | $6.85 | $20,550.00 | (< 1%) 580.68K to 577.68K | |
| 18-Jan-23 6:10 PM View: | Allogene Therapeutics, Inc. (ALLO) | 17-Jan-23 | Sale (Planned) | 3,000 | $7.04 | $21,120.00 | (< 1%) 583.68K to 580.68K | |
| 19-Dec-22 4:29 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Dec-22 | Sale (Planned) | 5,602 | $7.53 | $42,186.40 | (< 1%) 589.28K to 583.68K | |
| 25-Mar-22 5:49 PM View: | Allogene Therapeutics, Inc. (ALLO) | 23-Mar-22 | Grant | 175,438 | -- | -- | 42% 413.84K to 589.28K | |
| 17-Mar-22 5:59 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-22 | Sale | 8,849 | $7.68 | $67,962.10 | (2%) 422.69K to 413.84K | |
| 17-Sep-21 4:44 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Sep-21 | Option Exercise | 5,000 | $2.27 | $11,350.00 | 1% 421.67K to 426.67K | |
| 17-Sep-21 4:44 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Sep-21 | Market Option Sale (Planned) | 5,000 | $24.77 | $123,844.00 | (1%) 426.67K to 421.67K | |
| 17-Aug-21 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 16-Aug-21 | Option Exercise | 5,000 | $2.27 | $11,350.00 | 1% 421.35K to 426.35K | |
| 17-Aug-21 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 16-Aug-21 | Market Option Sale (Planned) | 5,000 | $21.00 | $104,994.00 | (1%) 426.35K to 421.35K | |
| 16-Jul-21 4:14 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Jul-21 | Option Exercise | 5,000 | $2.27 | $11,350.00 | 1% 421.35K to 426.35K | |
| 16-Jul-21 4:14 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Jul-21 | Market Option Sale (Planned) | 5,000 | $21.55 | $107,753.00 | (1%) 426.35K to 421.35K | |
| 16-Jun-21 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Jun-21 | Option Exercise | 5,000 | $2.27 | $11,350.00 | 1% 421.35K to 426.35K | |
| 16-Jun-21 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Jun-21 | Market Option Sale (Planned) | 5,000 | $25.32 | $126,600.00 | (1%) 426.35K to 421.35K | |
| 20-May-21 5:19 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-May-21 | Option Exercise | 5,000 | $2.27 | $11,350.00 | 1% 421.35K to 426.35K | |
| 20-May-21 5:19 PM View: | Allogene Therapeutics, Inc. (ALLO) | 18-May-21 | Market Option Sale (Planned) | 5,000 | $30.00 | $150,000.00 | (1%) 426.35K to 421.35K | |
| 17-May-21 5:16 PM View: | Allogene Therapeutics, Inc. (ALLO) | 17-May-21 | Option Exercise | 5,000 | $2.27 | $11,350.00 | 1% 421.35K to 426.35K | |
| 17-May-21 5:16 PM View: | Allogene Therapeutics, Inc. (ALLO) | 17-May-21 | Market Option Sale (Planned) | 5,000 | $28.30 | $141,476.00 | (1%) 426.35K to 421.35K | |
| 16-Apr-21 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Apr-21 | Option Exercise | 10,000 | $2.27 | $22,700.00 | 2% 421.35K to 431.35K | |
| 16-Apr-21 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Apr-21 | Market Option Sale (Planned) | 10,000 | $32.05 | $320,517.00 | (2%) 431.35K to 421.35K | |
| 30-Mar-21 4:55 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Mar-21 | Grant | 22,202 | -- | -- | 6% 399.15K to 421.35K | |
| 17-Mar-21 5:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-21 | Option Exercise | 10,000 | $2.27 | $22,700.00 | 2% 405.77K to 415.77K | |
| 17-Mar-21 5:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-21 | Market Option Sale | 6,623 | $38.16 | $252,730.00 | (2%) 415.77K to 409.15K | |
| 17-Mar-21 5:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-21 | Market Option Sale (Planned) | 3,377 | $37.81 | $127,674.00 | (< 1%) 409.15K to 405.77K | |
| 17-Mar-21 5:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Mar-21 | Market Sale (Planned) | 6,623 | $37.81 | $250,394.00 | (2%) 405.77K to 399.15K | |
| 18-Dec-20 4:34 PM View: | Allogene Therapeutics, Inc. (ALLO) | 17-Dec-20 | Option Exercise | 51,500 | $2.27 | $116,905.00 | 15% 353.9K to 405.4K | |
| 08-Oct-20 5:01 PM View: | Allogene Therapeutics, Inc. (ALLO) | 06-Oct-20 | Option Exercise | 10,000 | $2.27 | $22,700.00 | 3% 353.9K to 363.9K | |
| 08-Oct-20 5:01 PM View: | Allogene Therapeutics, Inc. (ALLO) | 06-Oct-20 | Market Option Sale (Planned) | 10,000 | $40.00 | $400,000.00 | (3%) 363.9K to 353.9K | 31% |
| 02-Oct-20 4:42 PM View: | Allogene Therapeutics, Inc. (ALLO) | 01-Oct-20 | Option Exercise | 25,000 | $2.27 | $56,750.00 | 7% 353.9K to 378.9K | |
| 02-Oct-20 4:42 PM View: | Allogene Therapeutics, Inc. (ALLO) | 01-Oct-20 | Market Option Sale (Planned) | 25,000 | $36.52 | $912,913.00 | (7%) 378.9K to 353.9K | 25% |
| 03-Sep-20 4:12 PM View: | Allogene Therapeutics, Inc. (ALLO) | 01-Sep-20 | Option Exercise | 25,000 | $2.27 | $56,750.00 | 7% 353.9K to 378.9K | |
| 03-Sep-20 4:12 PM View: | Allogene Therapeutics, Inc. (ALLO) | 01-Sep-20 | Market Option Sale (Planned) | 25,000 | $35.36 | $883,966.00 | (7%) 378.9K to 353.9K | 22% |
| 05-Aug-20 5:09 PM View: | Allogene Therapeutics, Inc. (ALLO) | 03-Aug-20 | Option Exercise | 25,000 | $2.27 | $56,750.00 | 7% 360.45K to 385.45K | |
| 05-Aug-20 5:09 PM View: | Allogene Therapeutics, Inc. (ALLO) | 03-Aug-20 | Market Option Sale (Planned) | 25,000 | $36.89 | $922,354.00 | (6%) 385.45K to 360.45K | 25% |
| 05-Aug-20 5:09 PM View: | Allogene Therapeutics, Inc. (ALLO) | 03-Aug-20 | Market Sale (Planned) | 6,553 | $36.89 | $241,767.00 | (2%) 360.45K to 353.9K | 25% |